Cargando…
Early Intervention for Spinal Cord Injury with Human Induced Pluripotent Stem Cells Oligodendrocyte Progenitors
Induced pluripotent stem (iPS) cells are at the forefront of research in regenerative medicine and are envisaged as a source for personalized tissue repair and cell replacement therapy. Here, we demonstrate for the first time that oligodendrocyte progenitors (OPs) can be derived from iPS cells gener...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4311989/ https://www.ncbi.nlm.nih.gov/pubmed/25635918 http://dx.doi.org/10.1371/journal.pone.0116933 |
_version_ | 1782355074659385344 |
---|---|
author | All, Angelo H. Gharibani, Payam Gupta, Siddharth Bazley, Faith A. Pashai, Nikta Chou, Bin-Kuan Shah, Sandeep Resar, Linda M. Cheng, Linzhao Gearhart, John D. Kerr, Candace L. |
author_facet | All, Angelo H. Gharibani, Payam Gupta, Siddharth Bazley, Faith A. Pashai, Nikta Chou, Bin-Kuan Shah, Sandeep Resar, Linda M. Cheng, Linzhao Gearhart, John D. Kerr, Candace L. |
author_sort | All, Angelo H. |
collection | PubMed |
description | Induced pluripotent stem (iPS) cells are at the forefront of research in regenerative medicine and are envisaged as a source for personalized tissue repair and cell replacement therapy. Here, we demonstrate for the first time that oligodendrocyte progenitors (OPs) can be derived from iPS cells generated using either an episomal, non-integrating plasmid approach or standard integrating retroviruses that survive and differentiate into mature oligodendrocytes after early transplantation into the injured spinal cord. The efficiency of OP differentiation in all 3 lines tested ranged from 40% to 60% of total cells, comparable to those derived from human embryonic stem cells. iPS cell lines derived using episomal vectors or retroviruses generated a similar number of early neural progenitors and glial progenitors while the episomal plasmid-derived iPS line generated more OPs expressing late markers O1 and RIP. Moreover, we discovered that iPS-derived OPs (iPS-OPs) engrafted 24 hours following a moderate contusive spinal cord injury (SCI) in rats survived for approximately two months and that more than 70% of the transplanted cells differentiated into mature oligodendrocytes that expressed myelin associated proteins. Transplanted OPs resulted in a significant increase in the number of myelinated axons in animals that received a transplantation 24 h after injury. In addition, nearly a 5-fold reduction in cavity size and reduced glial scarring was seen in iPS-treated groups compared to the control group, which was injected with heat-killed iPS-OPs. Although further investigation is needed to understand the mechanisms involved, these results provide evidence that patient-specific, iPS-derived OPs can survive for three months and improve behavioral assessment (BBB) after acute transplantation into SCI. This is significant as determining the time in which stem cells are injected after SCI may influence their survival and differentiation capacity. |
format | Online Article Text |
id | pubmed-4311989 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-43119892015-02-13 Early Intervention for Spinal Cord Injury with Human Induced Pluripotent Stem Cells Oligodendrocyte Progenitors All, Angelo H. Gharibani, Payam Gupta, Siddharth Bazley, Faith A. Pashai, Nikta Chou, Bin-Kuan Shah, Sandeep Resar, Linda M. Cheng, Linzhao Gearhart, John D. Kerr, Candace L. PLoS One Research Article Induced pluripotent stem (iPS) cells are at the forefront of research in regenerative medicine and are envisaged as a source for personalized tissue repair and cell replacement therapy. Here, we demonstrate for the first time that oligodendrocyte progenitors (OPs) can be derived from iPS cells generated using either an episomal, non-integrating plasmid approach or standard integrating retroviruses that survive and differentiate into mature oligodendrocytes after early transplantation into the injured spinal cord. The efficiency of OP differentiation in all 3 lines tested ranged from 40% to 60% of total cells, comparable to those derived from human embryonic stem cells. iPS cell lines derived using episomal vectors or retroviruses generated a similar number of early neural progenitors and glial progenitors while the episomal plasmid-derived iPS line generated more OPs expressing late markers O1 and RIP. Moreover, we discovered that iPS-derived OPs (iPS-OPs) engrafted 24 hours following a moderate contusive spinal cord injury (SCI) in rats survived for approximately two months and that more than 70% of the transplanted cells differentiated into mature oligodendrocytes that expressed myelin associated proteins. Transplanted OPs resulted in a significant increase in the number of myelinated axons in animals that received a transplantation 24 h after injury. In addition, nearly a 5-fold reduction in cavity size and reduced glial scarring was seen in iPS-treated groups compared to the control group, which was injected with heat-killed iPS-OPs. Although further investigation is needed to understand the mechanisms involved, these results provide evidence that patient-specific, iPS-derived OPs can survive for three months and improve behavioral assessment (BBB) after acute transplantation into SCI. This is significant as determining the time in which stem cells are injected after SCI may influence their survival and differentiation capacity. Public Library of Science 2015-01-30 /pmc/articles/PMC4311989/ /pubmed/25635918 http://dx.doi.org/10.1371/journal.pone.0116933 Text en © 2015 All et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article All, Angelo H. Gharibani, Payam Gupta, Siddharth Bazley, Faith A. Pashai, Nikta Chou, Bin-Kuan Shah, Sandeep Resar, Linda M. Cheng, Linzhao Gearhart, John D. Kerr, Candace L. Early Intervention for Spinal Cord Injury with Human Induced Pluripotent Stem Cells Oligodendrocyte Progenitors |
title | Early Intervention for Spinal Cord Injury with Human Induced Pluripotent Stem Cells Oligodendrocyte Progenitors |
title_full | Early Intervention for Spinal Cord Injury with Human Induced Pluripotent Stem Cells Oligodendrocyte Progenitors |
title_fullStr | Early Intervention for Spinal Cord Injury with Human Induced Pluripotent Stem Cells Oligodendrocyte Progenitors |
title_full_unstemmed | Early Intervention for Spinal Cord Injury with Human Induced Pluripotent Stem Cells Oligodendrocyte Progenitors |
title_short | Early Intervention for Spinal Cord Injury with Human Induced Pluripotent Stem Cells Oligodendrocyte Progenitors |
title_sort | early intervention for spinal cord injury with human induced pluripotent stem cells oligodendrocyte progenitors |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4311989/ https://www.ncbi.nlm.nih.gov/pubmed/25635918 http://dx.doi.org/10.1371/journal.pone.0116933 |
work_keys_str_mv | AT allangeloh earlyinterventionforspinalcordinjurywithhumaninducedpluripotentstemcellsoligodendrocyteprogenitors AT gharibanipayam earlyinterventionforspinalcordinjurywithhumaninducedpluripotentstemcellsoligodendrocyteprogenitors AT guptasiddharth earlyinterventionforspinalcordinjurywithhumaninducedpluripotentstemcellsoligodendrocyteprogenitors AT bazleyfaitha earlyinterventionforspinalcordinjurywithhumaninducedpluripotentstemcellsoligodendrocyteprogenitors AT pashainikta earlyinterventionforspinalcordinjurywithhumaninducedpluripotentstemcellsoligodendrocyteprogenitors AT choubinkuan earlyinterventionforspinalcordinjurywithhumaninducedpluripotentstemcellsoligodendrocyteprogenitors AT shahsandeep earlyinterventionforspinalcordinjurywithhumaninducedpluripotentstemcellsoligodendrocyteprogenitors AT resarlindam earlyinterventionforspinalcordinjurywithhumaninducedpluripotentstemcellsoligodendrocyteprogenitors AT chenglinzhao earlyinterventionforspinalcordinjurywithhumaninducedpluripotentstemcellsoligodendrocyteprogenitors AT gearhartjohnd earlyinterventionforspinalcordinjurywithhumaninducedpluripotentstemcellsoligodendrocyteprogenitors AT kerrcandacel earlyinterventionforspinalcordinjurywithhumaninducedpluripotentstemcellsoligodendrocyteprogenitors |